Literature DB >> 19339762

Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies.

David A Lewis1, Robert A Sweet.   

Abstract

Schizophrenia is a severe disorder that disrupts the function of multiple brain systems, resulting in impaired social and occupational functioning. The etiology and pathogenesis of schizophrenia appear to involve the interplay of a potentially large number of genetic liabilities and adverse environmental events that disrupt brain developmental pathways. In this Review, we discuss a strategy for determining how particular common and core clinical features of the illness are associated with pathophysiology in certain circuits of the cerebral cortex. The identification of molecular alterations in these circuits is providing critical insights for the rational development of new therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339762      PMCID: PMC2662560          DOI: 10.1172/JCI37335

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  120 in total

1.  Impaired precision, but normal retention, of auditory sensory ("echoic") memory information in schizophrenia.

Authors:  D C Javitt; R D Strous; S Grochowski; W Ritter; N Cowan
Journal:  J Abnorm Psychol       Date:  1997-05

2.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.

Authors:  L A Glantz; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2000-01

3.  Reduced dendritic spine density in auditory cortex of subjects with schizophrenia.

Authors:  Robert A Sweet; Ruth A Henteleff; Wei Zhang; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2008-05-07       Impact factor: 7.853

4.  Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.

Authors:  D C Javitt; M Steinschneider; C E Schroeder; J C Arezzo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory.

Authors:  S G Rao; G V Williams; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

6.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.

Authors:  D W Volk; M C Austin; J N Pierri; A R Sampson; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2000-03

Review 7.  Schizophrenia as a disorder of developmentally reduced synaptic connectivity.

Authors:  T H McGlashan; R E Hoffman
Journal:  Arch Gen Psychiatry       Date:  2000-07

8.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

Authors:  Y Okubo; T Suhara; K Suzuki; K Kobayashi; O Inoue; O Terasaki; Y Someya; T Sassa; Y Sudo; E Matsushima; M Iyo; Y Tateno; M Toru
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

9.  Associated deficits in mismatch negativity generation and tone matching in schizophrenia.

Authors:  D C Javitt; A Shelley; W Ritter
Journal:  Clin Neurophysiol       Date:  2000-10       Impact factor: 3.708

10.  Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects.

Authors:  W Gordon Frankle; Raymond Y Cho; Rajesh Narendran; N Scott Mason; Shivangi Vora; Maralee Litschge; Julie C Price; David A Lewis; Chester A Mathis
Journal:  Neuropsychopharmacology       Date:  2008-07-09       Impact factor: 7.853

View more
  111 in total

1.  Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial.

Authors:  Douglas L Boggs; Deanna L Kelly; Robert P McMahon; James M Gold; David A Gorelick; Jared Linthicum; Robert R Conley; Fang Liu; James Waltz; Marilyn A Huestis; Robert W Buchanan
Journal:  Schizophr Res       Date:  2011-12-03       Impact factor: 4.939

Review 2.  NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2012-02-21       Impact factor: 9.306

Review 3.  Is rational antipsychotic polytherapy feasible? A selective review.

Authors:  Rune Andreas Kroken; Erik Johnsen
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

4.  Reduced glutamate decarboxylase 65 protein within primary auditory cortex inhibitory boutons in schizophrenia.

Authors:  Caitlin E Moyer; Kristen M Delevich; Kenneth N Fish; Josephine K Asafu-Adjei; Allan R Sampson; Karl-Anton Dorph-Petersen; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2012-05-23       Impact factor: 13.382

Review 5.  Targeting glutamate synapses in schizophrenia.

Authors:  Julie R Field; Adam G Walker; P Jeffrey Conn
Journal:  Trends Mol Med       Date:  2011-09-28       Impact factor: 11.951

Review 6.  Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.

Authors:  Ana D Stan; David A Lewis
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

Review 7.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

8.  No association of psychosis in Alzheimer disease with neurodegenerative pathway genes.

Authors:  Mary Ann A DeMichele-Sweet; Lambertus Klei; Bernie Devlin; Robert E Ferrell; Elise A Weamer; James E Emanuel; Oscar L Lopez; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2010-11-18       Impact factor: 4.673

9.  Development of sensory gamma oscillations and cross-frequency coupling from childhood to early adulthood.

Authors:  Raymond Y Cho; Christopher P Walker; Nicola R Polizzotto; Thomas A Wozny; Catherine Fissell; Chi-Ming A Chen; David A Lewis
Journal:  Cereb Cortex       Date:  2013-12-10       Impact factor: 5.357

Review 10.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.